Axe Compute Free Cash Flow 2012-2026 | AGPU
Axe Compute free cash flow from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Axe Compute Annual Free Cash Flow | |
|---|---|
| 2025 | |
| 2024 | -10.98 |
| 2023 | -11.81 |
| 2022 | -12.79 |
| 2021 | -13.12 |
| 2020 | -12.36 |
| 2019 | -8.74 |
| 2018 | -5.47 |
| 2017 | -4.51 |
| 2016 | -4.41 |
| 2015 | -7.52 |
| 2014 | -3.47 |
| 2013 | -4.02 |
| 2012 | -1.18 |
| 2011 | -1.78 |
| Axe Compute Quarterly Free Cash Flow | |
|---|---|
| 2026-03-31 | |
| 2025-12-31 | |
| 2025-09-30 | -5.94 |
| 2025-06-30 | -4.28 |
| 2025-03-31 | -0.99 |
| 2024-12-31 | -10.98 |
| 2024-09-30 | -8.05 |
| 2024-06-30 | -5.51 |
| 2024-03-31 | -2.71 |
| 2023-12-31 | -11.81 |
| 2023-09-30 | -9.10 |
| 2023-06-30 | -7.28 |
| 2023-03-31 | -3.45 |
| 2022-12-31 | -12.79 |
| 2022-09-30 | -9.50 |
| 2022-06-30 | -6.66 |
| 2022-03-31 | -3.14 |
| 2021-12-31 | -13.12 |
| 2021-09-30 | -9.18 |
| 2021-06-30 | -6.14 |
| 2021-03-31 | -3.71 |
| 2020-12-31 | -12.36 |
| 2020-09-30 | -9.93 |
| 2020-06-30 | -6.59 |
| 2020-03-31 | -2.97 |
| 2019-12-31 | -8.74 |
| 2019-09-30 | -5.94 |
| 2019-06-30 | -4.05 |
| 2019-03-31 | -2.05 |
| 2018-12-31 | -5.47 |
| 2018-09-30 | -4.24 |
| 2018-06-30 | -3.24 |
| 2018-03-31 | -1.73 |
| 2017-12-31 | -4.51 |
| 2017-09-30 | -3.18 |
| 2017-06-30 | -2.11 |
| 2017-03-31 | -1.18 |
| 2016-12-31 | -4.41 |
| 2016-09-30 | -3.73 |
| 2016-06-30 | -2.80 |
| 2016-03-31 | -1.61 |
| 2015-12-31 | -7.52 |
| 2015-09-30 | -4.64 |
| 2015-06-30 | -0.22 |
| 2015-03-31 | -0.01 |
| 2014-12-31 | -3.47 |
| 2014-09-30 | -3.25 |
| 2014-06-30 | -2.02 |
| 2014-03-31 | -1.83 |
| 2013-12-31 | -4.02 |
| 2013-09-30 | -3.39 |
| 2013-06-30 | -2.13 |
| 2013-03-31 | -0.94 |
| 2012-12-31 | -1.18 |
| 2012-09-30 | -0.78 |
| 2012-06-30 | -0.64 |
| 2012-03-31 | -0.25 |
| 2011-12-31 | -1.78 |
| 2011-09-30 | -1.19 |
| 2011-06-30 | -0.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.022B | $0.000B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |